PT-141, also known as Bremelanotide, is a breakthrough peptide therapy designed to enhance sexual arousal and desire in both men and women by acting directly on the central nervous system. Unlike traditional hormone-based treatments, PT-141 works through the melanocortin receptors in the brain to activate natural arousal pathways—making it a safe, effective, and non-hormonal option for patients seeking improved sexual health and emotional well-being.
Our lyophilized peptides deliver 99%+ purity and are manufactured in the USA with APIs listed on the FDA Green List. We partner exclusively with cGMP and ISO 9001 registered facilities to ensure that every ingredient meets stringent purity and efficacy benchmarks, guaranteeing consistency and efficacy across all production runs. Certificate of Analysis available upon request.
Key Benefits for Your Patients:
- Enhanced Sexual Desire and Arousal: Stimulates natural libido in both men and women through central nervous system activation.
- Improved Performance and Satisfaction: Promotes stronger sexual response and increased sensitivity for a more fulfilling experience.
- Effective for Both Genders: Clinically shown to improve sexual arousal disorders in women and support erectile function in men.
- Non-Hormonal: Works independently of sex hormones, offering an alternative for patients who cannot tolerate or prefer to avoid hormonal therapy.
- Emotional and Psychological Benefits: May enhance mood, confidence, and emotional connection by reducing stress and improving overall well-being.
PT-141 provides a neuroscience-driven solution for sexual health that complements both aesthetic and wellness practices. Its non-hormonal, targeted mechanism allows providers to safely and effectively address low libido and sexual dysfunction, improving both physical and emotional aspects of intimacy and quality of life.
Each vial is provided in lyophilized powder form and must be reconstituted with bacteriostatic water prior to use.
This product is intended for use under the guidance of qualified medical professionals who prioritize precision, quality, and evidence-based peptide therapies in patient care.
